Wipfli Financial Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Wipfli Financial Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5K	Buy	+260	New	+$4.74K	﹤0.01%	2109

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wipfli Financial Advisors's CDMO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022: 260 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #2109 among its holdings.

184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

Wipfli Financial Advisors held 260 shares of Avid Bioservices, Inc. Common Stock worth $5K as of Q3 2022.
Avid Bioservices, Inc. Common Stock was a new Wipfli Financial Advisors position in Q3 2022.
Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2109 holding.
184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.